50
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
0.214
Exchange
XHKG - Hong Kong Exchange
6 %
Last period ROE
2%
ROE has increased in 5 years
What is ROE ?
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Lansen Pharmaceutical
Company Analysis
503.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
503.HK financial analysis by Eyestock methodology
Valuation
503.HK valuation using historical relative method
Statements
503.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
503.HK dividend yield and annual dividend
The return on equity ratio shows how much net profit a company earns per unit of equity. To calculate the company's rating, the return on equity adjusted for the average level of financial leverage for 3 years is taken into account. The value of 20% is the benchmark for Eyestock Rating calculation.
Lansen Pharmaceutical`s ROE for the last twelve months ended 2023-06-30 is 6 %
